Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$17.18 - $22.38 $48,619 - $63,335
-2,830 Reduced 14.25%
17,030 $336,000
Q3 2023

Nov 13, 2023

BUY
$15.0 - $20.71 $297,900 - $411,300
19,860 New
19,860 $391,000
Q3 2020

Oct 30, 2020

SELL
$29.04 - $37.49 $3.73 Million - $4.81 Million
-128,300 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$20.16 - $34.84 $381,427 - $659,172
-18,920 Reduced 12.85%
128,300 $4.47 Million
Q1 2020

May 11, 2020

SELL
$16.59 - $34.94 $793,483 - $1.67 Million
-47,829 Reduced 24.52%
147,220 $3.42 Million
Q4 2019

Feb 13, 2020

BUY
$22.24 - $27.56 $4.34 Million - $5.38 Million
195,049 New
195,049 $4.89 Million

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.